ROS1 and non-small cell lung carcinoma: In order to showcase the representativity of the patient-derived cell lines used in the study, special attention was paid to genes involved in extrinsic resistance mechanisms towards TKIs described in ROS1+ NSCLC patients (Figure 3C).